So, afatinib is this inhibitor thing that goes after EGFR and HER2 proteins. It’s used to treat a type of lung cancer called NSCLC, especially in people who have specific changes in the EGFR gene. The deal with afatinib is that it’s supposed to stop these EGFR pathways in their tracks.
You can get afatinib in tablets that come in 20, 30, or 40-milligram doses. The usual dose is 40 mg, taken once a day, ideally on an empty stomach. These tablets come in bottles of 30.